May 2024
In this month's issue of Corporate Financier, life sciences M&A is under the microscope; dealmaking in the South of England is not just about being a London satellite; and August Equity invests in public sector software-as-a-service businesses.
long read
Healthy outlook: life sciences M&A
News and views
May 2024
Dates for the diary, including an infrastructure seminar in Leeds, plus the faculty’s input at recent events.
Read moreJon Moulton on HMRC’s PISCES regime
The only stars in Jon Moulton’s eyes are the ones brought on by a dizzy turn from yet more regulation.
Read moreTime for a deal
We take a look at the UK and global M&A trends of Q1 2024, as shown by the latest surveys.
Read moreGlobal investment and M&A
Insider dealing: August Equity’s MBO of StarTraq
Analysis: PE in the UK mid-market
Innovation and sustainable recovery
Roadshow: Southern charms
- Article
- 10 May 2024
- Nicholas Neveling
Future advisory professionals
profile
A road less well travelled
Relishing challenges and learning from experiences are what makes an M&A adviser. Marc Mullen speaks to Taylor Wessing's Deepti Patankar.
Read morecareer paths
Legally speaking
Ellie Shanahan, corporate associate at Burges Salmon, reveals how her career in corporate law fulfils a desire to be constantly learning.
Read moreon my cv
Skin in the game
Victoria Kisseleva of FRP Corporate Finance on finding the right due diligence balance when advising private equity on a sector that’s new to them.
Read moreThe archives
Browse Corporate Financier content from July/August 2024 and earlier.